10-Q Filing

REGENXBIO INC. CIK: 1590877 Q1 2023

Filing Information

Form Type	10-Q
Accession Number	`0000950170-23-017200`
Period End Date	20230331
Filing Date	20230503
Fiscal Year	2023
Fiscal Period	Q1
XBRL Instance	rgnx-20230331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 80 Income Statement 41 Cash Flow Statement 62 Stockholders Equity 20

Balance Sheet 80 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$191.87M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$96.95M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$70.09M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$267.69M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$261.73M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$28.08M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$18.86M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$13.90M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$15.52M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	43.30M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$9.35M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$23.00M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	43.47M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$415.98M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	43.30M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$389.20M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	43.47M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$141.71M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$200.56M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetNoncurrent`	$1.50M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetNoncurrent`	$1.30M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$141.69M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$141.57M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$65.12M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$63.73M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$2.03M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$2.03M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$2.03M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$8.29M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.40M	USD	Point-in-time
Total assets	`Assets`	$747.83M	USD	Point-in-time
Total assets	`Assets`	$833.27M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$23.28M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$27.21M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$46.79M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$31.71M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$1.31M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$1.83M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$6.00M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$6.30M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesCurrent`	$49.73M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesCurrent`	$48.60M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$130.43M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$112.33M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$88.80M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$86.99M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesNonCurrent`	$89.00M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesNonCurrent`	$77.38M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$5.98M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$8.83M	USD	Point-in-time
Total liabilities	`Liabilities`	$282.69M	USD	Point-in-time
Total liabilities	`Liabilities`	$317.07M	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at March 31, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at March 31, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at March 31, 2023 and December 31, 2022; 43,465 and 43,299 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively	`CommonStockValue`	$4.00K	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at March 31, 2023 and December 31, 2022; 43,465 and 43,299 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively	`CommonStockValue`	$4.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$984.99M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$973.14M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-11.62M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-15.40M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-441.55M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-508.23M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$689.67M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$516.20M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$764.30M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$465.14M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$747.83M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$833.27M	USD	Point-in-time

Income Statement 41 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$19.14M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$22.22M	USD	1 Quarter
Cost of revenues	`CostOfGoodsAndServicesSold`	$4.11M	USD	1 Quarter
Cost of revenues	`CostOfGoodsAndServicesSold`	$15.72M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$55.63M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$58.52M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$22.32M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$22.63M	USD	1 Quarter
Other operating expenses	`OtherOperatingExpenses`	$83.00K	USD	1 Quarter
Other operating expenses	`OtherOperatingExpenses`	$33.00K	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$85.30M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$93.75M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-66.16M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-71.53M	USD	1 Quarter
Interest income from licensing	`InterestIncomeFromLicencing`	$70.00K	USD	1 Quarter
Interest income from licensing	`InterestIncomeFromLicencing`	$94.00K	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$799.00K	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$2.17M	USD	1 Quarter
Interest expense	`InterestExpense`	$6.13M	USD	1 Quarter
Interest expense	`InterestExpense`	$2.75M	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-519.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-5.24M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-66.68M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-76.76M	USD	1 Quarter
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-41.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-66.68M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-76.72M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-9.38M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$3.78M	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-9.38M	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$3.78M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-86.10M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-62.90M	USD	1 Quarter
Net loss per share, basic	`EarningsPerShareBasic`	$-1.79	USD	1 Quarter
Net loss per share, basic	`EarningsPerShareBasic`	$-1.53	USD	1 Quarter
Net loss per share, diluted	`EarningsPerShareDiluted`	$-1.53	USD	1 Quarter
Net loss per share, diluted	`EarningsPerShareDiluted`	$-1.79	USD	1 Quarter
Weighted-average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	43,451.00	shares	1 Quarter
Weighted-average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	42,944.00	shares	1 Quarter
Weighted-average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	43,451.00	shares	1 Quarter
Weighted-average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	42,944.00	shares	1 Quarter

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-76.72M	USD	1 Quarter
Net loss	`ProfitLoss`	$-66.68M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$10.80M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$11.21M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$4.18M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$2.59M	USD	1 Quarter
Net amortization of premiums on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-682.00K	USD	1 Quarter
Net amortization of premiums on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.46M	USD	1 Quarter
Imputed interest income from licensing	`ImputedInterestIncomeFromLicensing`	$94.00K	USD	1 Quarter
Imputed interest income from licensing	`ImputedInterestIncomeFromLicensing`	$70.00K	USD	1 Quarter
Non-cash interest expense	`NonCashInterestExpense`	$54.00K	USD	1 Quarter
Non-cash interest expense	`NonCashInterestExpense`	$-574.00K	USD	1 Quarter
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$52.00K	USD	1 Quarter
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$43.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-9.49M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-5.69M	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$1.62M	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-210.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$13.65M	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-3.04M	USD	1 Quarter
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$-1.39M	USD	1 Quarter
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$-979.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$2.10M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$1.89M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$16.75M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-3.10M	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-15.44M	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-26.47M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-433.00K	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$1.01M	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-1.50M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-2.85M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$6.93M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-80.92M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-55.91M	USD	1 Quarter
Purchases of marketable debt securities	`PaymentsToAcquireMarketableSecurities`	$129.49M	USD	1 Quarter
Maturities of marketable debt securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$49.86M	USD	1 Quarter
Maturities of marketable debt securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$67.91M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.82M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$10.97M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$63.09M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-90.59M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$471.00K	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$337.00K	USD	1 Quarter
Taxes paid related to net settlement of stock-based awards	`TaxesPaidRelatedToNetSettlementOfStockBasedAwards`	$419.00K	USD	1 Quarter
Taxes paid related to net settlement of stock-based awards	`TaxesPaidRelatedToNetSettlementOfStockBasedAwards`	$284.00K	USD	1 Quarter
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$622.00K	USD	1 Quarter
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$583.00K	USD	1 Quarter
Repayments under liability related to sale of future royalties, net of imputed interest	`RepaymentsUnderLiabilityRelatedToSaleOfFutureRoyalties`	$9.67M	USD	1 Quarter
Repayments under liability related to sale of future royalties, net of imputed interest	`RepaymentsUnderLiabilityRelatedToSaleOfFutureRoyalties`	$7.51M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-6.83M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-9.04M	USD	1 Quarter
Net decrease in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-153.34M	USD	1 Quarter
Net decrease in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-26.86M	USD	1 Quarter
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$193.90M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$347.24M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$72.12M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$98.98M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$193.90M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$347.24M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$72.12M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$98.98M	USD	Point-in-time

Stockholders Equity 20 line items

Line Item	Tag	Value	Unit	Period
Balances	`StockholdersEquity`	$689.67M	USD	Point-in-time
Balances	`StockholdersEquity`	$516.20M	USD	Point-in-time
Balances	`StockholdersEquity`	$764.30M	USD	Point-in-time
Balances	`StockholdersEquity`	$465.14M	USD	Point-in-time
Vesting of restricted stock units, net of tax	`VestingOfRestrictedStockUnits`	$-284.00K	USD	1 Quarter
Vesting of restricted stock units, net of tax	`VestingOfRestrictedStockUnits`	$-419.00K	USD	1 Quarter
Exercise of stock options, net of tax	`StockIssuedDuringPeriodValueStockOptionsExercised`	$337.00K	USD	1 Quarter
Exercise of stock options, net of tax	`StockIssuedDuringPeriodValueStockOptionsExercised`	$471.00K	USD	1 Quarter
Issuance of common stock under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$583.00K	USD	1 Quarter
Issuance of common stock under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$622.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.80M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.21M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-9.38M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$3.78M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-66.68M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-76.72M	USD	1 Quarter
Balances	`StockholdersEquity`	$689.67M	USD	Point-in-time
Balances	`StockholdersEquity`	$516.20M	USD	Point-in-time
Balances	`StockholdersEquity`	$764.30M	USD	Point-in-time
Balances	`StockholdersEquity`	$465.14M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.